|
Home
Search
Study Topics
Glossary
|
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
![]() |
||||||||||||||||||||||||||||||||||||
| Sponsored by: |
Forschungsinstitut für Balneologie und Kurortwissenschaft Bad Elster |
|---|---|
| Information provided by: | Forschungsinstitut für Balneologie und Kurortwissenschaft Bad Elster |
| ClinicalTrials.gov Identifier: | NCT00324441 |
Purpose
The purpose of the study is to evaluate whether mild walter-filtered near infrared hyperthermia produces an additional benefit when applied as an adjunct to standard multimodal rehabilitation compared to standard multimodal rehabilitation only in patients with fibromyalgia.
| Condition | Intervention | Phase |
|---|---|---|
|
Fibromyalgia |
Device: Iratherm® 1000 |
Phase II |
| Study Type: | Interventional |
| Study Design: | Treatment, Randomized, Open Label, Active Control, Parallel Assignment, Efficacy Study |
| Official Title: | A Randomized Controlled Trial on the Effectiveness of Mild Water-Filtered Near Infrared Hyperthermia as an Adjunct to a Standard Multimodal Rehabilitation in the Treatment of Fibromyalgia |
| Estimated Enrollment: | 132 |
| Study Start Date: | January 2004 |
| Estimated Study Completion Date: | July 2005 |
Mild systemic heat agents, including infrared whole-body hyperthermia, are used as treatment options in multimodal rehabilitation programs for fibromyalgia in Germany. However, no randomized controlled clinical trial exists on their effectiveness for this condition.
This study is designed as an add-on study to evaluate the additional benefit of mild walter-filtered near infrared hyperthermia and a standard multimodal rehabilitation program compared to a standard multimodal rehabilitation program only. Standard multimodal rehabilitation is configured as usually applied in clinical trials with exercise, cognitive behavioral therapy, and health education as the main treatment components.
Mild walter-filtered near infrared hyperthermia (heating-up to 38.1 degrees C body core temperature followed by a 15-min heat retention period) is administered twice a week over 3 weeks during a rehabilitation hospital stay. Primary outcome measures are measured at baseline, postintervention, 3 and 6 months postintervention. Analysis is done by intention to treat, for significance testing Repeated Measures ANCOVA is used.
Eligibility| Ages Eligible for Study: | 18 Years to 70 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Contacts and Locations| Germany, Hessen | |
| Rehabilitationsklinik Hoher Meissner | |
| Bad Sooden-Allendorf, Hessen, Germany, 37242 | |
| Study Chair: | Thomas Brockow, MD | FBK Bad Elster |
More Information
| Study ID Numbers: | WBH-FM-1 |
| Study First Received: | May 9, 2006 |
| Last Updated: | May 9, 2006 |
| ClinicalTrials.gov Identifier: | NCT00324441 History of Changes |
| Health Authority: | Germany: Federal Institute for Drugs and Medical Devices |
|
Fibromyalgia Rehabilitation Physical Medicine Whole-Body Hyperthermia Water-Filtered Near Infrared |
|
Fever Signs and Symptoms Muscular Diseases Neuromuscular Diseases Musculoskeletal Diseases |
Myofascial Pain Syndromes Fibromyalgia Pain Rheumatic Diseases |
|
Fever Signs and Symptoms Muscular Diseases Neuromuscular Diseases Musculoskeletal Diseases |
Myofascial Pain Syndromes Fibromyalgia Nervous System Diseases Rheumatic Diseases Body Temperature Changes |